High expression of BECLIN 1 along with low expression of BCL-2 associates with good prognosis in non-Hodgkin lymphomas [35] and, conversely, low expression of BECLIN 1 with high expression of BCL-xL associated with poor prognosis in hepatocellular carcinomas [36]. The gene discussed is BECN1; the disease is non-Hodgkin lymphoma.